A model has been proposed in which, in the absence of TSH, the extracellular domain of the TSH receptor would exert a silencing effect on the serpentine domain involved in activation of the G ␣s protein. Mutation of S281 in the ectodomain is supposed to release this constraint, thereby causing receptor activation. This defines S281 and its neighbors as a segment important in intramolecular signal transduction. The functional importance of this segment was explored by site-directed mutagenesis experiments involving S281, as well as the two cysteine residues (C283, C284) present immediately downstream. S281 was mutated to N, T, G, and A in this study, and the functional characteristics of the mutants were compared. We found that S281N, S281T, and S281G display stronger constitutive activity than S281A mutant, suggesting that increase in constitutive activity is related to the extent of disruption of the local structure of the ectodomain. C283 and C284, the two consecutive cysteines that are highly conserved in glycoprotein hormone receptors, were mu-tated to serine, either alone (S281HSC or S281HCS) or in combination (S281HSS) and were studied in two different TSH receptor backgrounds. The mutated cysteine ectodomains were either linked to a glycosylphosphatidylinositol anchor or the serpentine domain of the wild-type holoreceptor. Glycosylphosphatidylinositol-anchored ectodomain receptors showed good cell surface expression in CHO cells, but only S281HCS was able to bind TSH specifically, illustrating the importance of C283, or the putative disulphide bond, in maintaining the conformation of the ligand binding site. In contrast, cysteine mutants on an extracellular domain-holoreceptor background displayed severely impaired membrane targeting and were poorly expressed in COS cells. However, basal cAMP production, normalized to expression at the plasma membrane, indicated significant increase in constitutive activity of all three mutants, compared with the wildtype receptor. Altogether, these findings support a model in which the ectodomain would act as a silencer of the basal activity of the serpentine portion of the receptor.
A MEMBER OF THE G protein-coupled receptor (GPCR) gene family, the TSH receptor (TSHr) is particularly prone to activation by a wide spectrum of spontaneous mutations. The result is a constitutive activation of the adenylylcyclase-dependent regulatory cascade, which is responsible for acquired or hereditary forms of hyperthyroidism (1) (2) (3) (4) (5) (6) (7) (8) (9) . The majority of these activating mutations correspond to amino acid substitutions, which are widely distributed over the serpentine structure of the receptor (10) . This observation, together with the demonstration that the wild-type (WT) TSHr, contrary to its near homologues (the LH/CG receptor and the FSH receptor), displays significant constitutive activity, led to the suggestion that the unliganded inactive TSHr was structurally less constrained than many other GPCRs, thus being more susceptible to activation by relatively minor structural changes (10, 11) .
Interestingly, a number of the activating mutations have been identified in the extracellular loops of the serpentine portion of the receptor and even in the aminoterminal extracellular domain (ECD) responsible for the high-affinity binding of TSH (8, 11, 12) . Serine 281 in the ECD, when mutated to three different residues (i.e. isoleucine, threonine, and asparagine), strongly increases the basal stimulation of adenylylcyclase by the receptor (11, 12) . In addition, treatment of cells expressing the receptor with low concentrations of trypsin results in partial activation of the receptor, while removing an epitope from the ECD (13) . From these observations, we have proposed that the ECD would contribute to the silencing of an inherently noisy serpentine portion of the TSHr (10, 11) . This model implies that interaction(s) between specific regions of the ECD and the extracellular loops of the serpentine portion would exist, whereby this silencing effect would be exerted. Recent experiments dealing with expression of chimeric receptors have provided arguments in favor of this model (Ref. 14 
and our unpublished observations).
In the present study, the changes in constitutive activity of the TSHr upon mutation at the critical S281 to amino acids N, T, G, and A were compared. We found that increase in constitutive activity is related to the expected magnitude of the effects of the mutations on local structure, being minimal in the S281A mutant. In addition, we also explored the functional importance of two highly conserved cysteine residues of the ECD situated in the immediate vicinity of serine 281 (Cys 283 and Cys 284). Being close to a residue of the ECD whose mutation activates the receptor constitutively, we reasoned that they (or, more likely, the structure stabilized by the disulfide bridges they make) may contribute to the silencing effect of the ECD. Cysteines 283 and 284 were mutated to serine, either singly (S281HSC or S281HCS) or in combination (S281HSS) on the background of the holoreceptor or on the ECD expressed separately as a glycosylphosphatidylinositol(GPI)-anchored molecule (ECD-GPI) (15) . The results point to an important structural role of C283 in allowing folding of the ECD into a structure capable of binding TSH. In addition, all three mutant receptor constructs (S281HSC, S281HCS, and S281HSS) displayed increase in their basal activity, thus providing additional support to the notion that a specific structure of the ECD is involved in keeping silent the serpentine portion of the receptor.
Materials and Methods

Generation of the ECDs with serine and cysteine mutations
Both the serine and cysteine mutants were generated by the Quick-Change site mutagenesis method, starting with TSHr in pBluescript SKϩ and two synthetic oligonucleotide primers containing the desired mutation(s). The primers used for the serine and cysteine mutations were as followed: 1) Serine mutants: forward primers 5ЈGCT GAC CTT TCT  TAC CCA AAC CAC TGC TGT GCT TTT AAG A3Ј for S281N, 5ЈGCT  GAC CTT TCT TAC CCA ACG CAC TGC TGT GCT TTT AAG A3Ј for  S281T, 5ЈGCT GAC CTT TCT TAC CCA GGG CAC TGC TGT GCT TTT  AAG A3Ј for S281G, and 5ЈGCT GAC CTT TCT TAC CCA GCT CAC  TGC TGT GCT TTT AAG A3Ј for S281A; 2) Cysteine mutants: forward  primers 5ЈGCT GAC CTT TCT TAC CCA AGC CAC AGC TGT GCT TTT  AAG A3Ј for S281HSC, 5ЈGCT GAC CTT TCT TAC CCA AGC CAC TGC  AGT GCT TTT AAG A3Ј for S281HCS, and 5ЈGCT GAC CTT TCT TAC  CCA AGC CAC AGC AGT GCT TTT AAG A3Ј for S281HSS; and reverse  primer 5ЈGGT AAG AAA GGT CAG CCC GTG TGA GGT GAA GGA  AAC TCA A3Ј , which was used in all the mutants. The pair of forward and reverse oligonucleotide primers, each complementary to opposite strands of the vector, was extended during temperature cycling by PfuTurbo DNA polymerase (Stratagene, La Jolla, CA). After temperature cycling, the product was treated with Dpn1, which enabled the digestion of parental methylated template and selection for the synthesized DNA containing mutations, which was then transformed into Escherichia coli. Introduction of mutations had generated additional restriction enzyme sites with PvuII for S281HSC and PstI for S281HCS, whereas direct sequencing allowed for selection of positive colonies for the S281HSS and all the S281 mutations. Recombinant DNA from selected clones was purified and sequenced again for direct confirmation of mutation.
Cysteine mutant ECD-GPI constructs. An AatII-NdeI fragment from each cysteine mutant obtained above was inserted in the complementary DNA (cDNA) coding for the WT (S281HCC) TSHr ECD-GPI construct in pEFIN3 vector (Euroscreen, Brussels, Belgium). Transfection was done in CHO-K1 cells and followed by selection with Geneticin G418. Clones carrying high levels of receptor expression were isolated by limit dilution.
Serine and cysteine mutant ECD-holoreceptor constructs. After restriction enzyme digestion with XhoI and EcoRV, mutated serine and cysteine ECDs from the above described constructs were ligated into the fulllength TSHr cDNA in pBluescript SKϩ, which had an EcoRV site engineered at the CEDIM (408 -412) motif. A XbaI-KpnI fragment from each mutant was inserted into the pcDNA3 vector (Invitrogen, Groningen, The Netherlands). For the cysteine ECD-holoreceptors, transient transfection was done with 2 g DNA for each construct in 300,000 COS 7, using FUGENE 6 transfection reagent (Roche Molecular Bio-chemicals, Mannheim, Germany) according to the manufacturer's protocol, whereas transfection of serine mutants was performed by the DEAE-dextran method followed by a dimethylsulfoxide shock (16) . Cells transfected with the empty vector or the cDNA of TSHr served as negative and positive controls, respectively.
Characterization of serine and cysteine mutants
Flow cytofluorometry. Monoclonal antibodies (mAb) BA8 and 15.2 were used for the experiments as described previously (15) . BA8 recognizes a conformational epitope on the TSHr (15) localized between amino acids 21 and 164 (localization determined by FACS with TSHr/LHr and human TSHr/rat TSHr chimeric receptors; our unpublished results), whereas 15.2 (Costagliola, S., unpublished results) recognizes a linear epitope located close to the C-terminal portion of the ECD from the amino acid residues 371-400.
TSH binding assay. For TSH binding, cells were washed twice with binding assay buffer (NaCl-free HBSS containing 277 mm sucrose, 5% BSA, and 25 mm HEPES, pH 7.4) and incubated with 100,000 cpm/ml 125 I-labeled TSH (58 CI/g, BRAHMS Diagnostics, Berlin, Germany) for 4 h at room temperature, with or without unlabeled TSH (Sigma-Aldrich Corp., Bornem, Belgium). The cells were then washed twice with cold (4 C) buffer, subsequently solubilized with 1 m NaOH, and the radioactivity was determined in a ␥ counter. cAMP determination. These were done only on COS cells transfected with the mutant ECD-holoreceptors, after 1 h incubation in the presence of 25 m Rolipram (Laboratoire Logeais, Paris, France) with or without TSH, as detailed previously (13) .
Computation of specific constitutive activity (SCA) and relative SCA (RSCA).
Given that the transfection efficiency for each construct is constant for a given batch of cells, the SCA is calculated by:
where A R and A V are the cAMP of cells transfected with the mutant construct and vector, respectively, and F R and F V are the corresponding mean fluorescence unit obtained with FACS analyses.
RSCA, which is normalized to the WT TSHr, is obtained by: RSCA ϭ SCA R /SCA WT
Western blotting
Preparation of receptor. Six dishes, each containing 300,000 cells transfected with mutant ECD-holoreceptor constructs, were detached with 5 mm EDTA and 5 mm EGTA in PBS and spun down at 280 ϫ g to obtain a cell pellet, which was resuspended and homogenized in a Potter-Elvehjem glass homogenizer with a Teflon pestle in 1250 l lysis buffer (100 mm (NH4) 2 SO 4 , 20 mm Tris at pH 7.5, and 10% glycerol) containing protease inhibitors (Complete, Roche Molecular Biochemicals). The lysate was then centrifuged at 500 ϫ g for 10 min, and the supernatant was recovered for further ultracentrifugation at 30,000 ϫ g for 30 min. Two hundred microliters of lysis buffer, containing 1% N-dodecyl-␤-dmaltoside (Anatrace, Maumee, OH), was added to the pellet; and the suspension was incubated for another 30 min, at 4 C, under constant rotation to allow thorough mixing. Final centrifugation was carried out at 100,000 ϫ g for 1 h, and the supernatant was stored at Ϫ80 C for further use. All procedures described were performed at 4 C.
Immunoblotting. Three microliters of Laemli sample buffer (5ϫ) containing SDS and ␤-mercpathoethanol as a reducing agent, were added to 10 l receptor protein prepared as above and denatured at 40 C for 1 h. The sample was then run on 7% acrylamide gel and probed with the mAb 28 (culture supernatant diluted 1:50), which recognizes a linear epitope at the N-terminal of the ECD from amino acid residues 31-50 (Costagliola, S., to be published). The proteins were visualized with an antimouse IgG horseradish peroxidase conjugate and the ECL Plus Western blotting detection system (Amersham Pharmacia Biotech, Benelux, The Netherlands). Figure 1 illustrates alignment of the region of glycoprotein hormone receptors downstream of the last leucine repeat. As can been seen, the CCAF tetrapeptide, two residue downstream of Ser281 (numbering of the TSHr), is almost invariant in the TSH, LH/CG, and FSH receptors, as well as in related orphan receptors of mammalian, drosophila, or nematode origins. Their proximity with the functionally important Ser281 residue, whose mutation activates the receptor constitutively, and their conservation at the C-terminal frontier downstream to the leucine repeats of the ECDs in all members of the glycoprotein hormone receptor family, suggested that Cys 283 and Cys284, or the structure they stabilize via disulfide bonding, would be important for intramolecular signal transduction. It was thus decided to mutate them to serine, alone or in combination, and to explore the effect of such mutations both on the ability of the ECD to fold normally and bind TSH, and on the basal activity of the receptor. An interplay has been demonstrated between the ectodomain and the serpentine domain, explaining the gain in affinity for TSH binding displayed by constitutively active TSHr mutants (17) . To avoid possible interference resulting from this interaction, the effect of Cys 283 and Cys284 mutations was tested on the ECD expressed as a GPI-anchored molecule, i.e. devoid of the serpentine domain. The same mutations were engineered on the background of the holoreceptor to explore their effects on basal receptor activity.
Results
Conservation of cysteines 283 and 284 among glycoprotein hormone receptors
Mutant ECD-GPI constructs
The two single mutants (S281HCS and S281HSC) and the double mutant (S281HSS) were constructed on the framework of the GPI-anchored ECD described previously and expressed in CHO cells (Fig. 2, A and B) . Representative clones were selected that displayed expression levels corresponding to the average of the mixes. They were evaluated by FACS analyses with two different mAb: mAb BA8 recognizes a conformational epitope located in the aminoterminal portion of the ECD (15), and mAb 15.2 recognizes a linear epitope at the C-terminal end of ECD. When compared with S281HCC (WT), S281HSS showed the highest level of receptor expression, followed by S281HCS and S281HSC (Fig. 2B ). Only the S281HCS mutant showed sizable specific binding of TSH that was displaceable with unlabeled hormone (Fig. 3A) . Displacement of 125 I-labeled TSH bound to this mutant receptor by unlabeled hormone was similar to the WT receptor, with dissociation constants of 1.6 mUI/ml and 2.1 mUI/ml, respectively (Fig. 3B ). Mutating Cys 283 (as in S281HSC) abolished this binding ability, emphasizing the importance of Cys 283 in maintaining conformation of the binding site. It was also apparent from the above findings that Cys 284 is involved to a lesser extent in this functional aspect of the TSHr. Although well expressed on the cell surface, the double-mutant S281HSS showed only marginal TSH binding capability (Fig. 3A) . In all cases, recognition of the mutants was similar with both mAb, suggesting that the conformational changes did not involve destruction of the conformational epitope of mAb BA8.
Mutant ECD-holoreceptor constructs
In contrast to the GPI constructs, cysteine mutants on the background of the holoreceptor showed limited cell surface expression ( Fig. 4A ). mAb 15.2, whose linear epitope is located just upstream of the first transmembrane segment, was able to recognize the cysteine mutants better than BA8 (Fig.  4B ). This could be explained, in part, by the difference in the epitopes recognized by both antibodies. Conformational changes in the ECD as a result of cysteine mutation would have diminished the binding of BA8 (conformational epitope) without affecting recognition by 15.2. However, FACS studies on permeabilized cells showed that mAb BA8 was able to recognize the mutant receptors and that most of these receptors were sequestrated intracellularly (Fig. 4C ). Western blots of mutant receptors prepared from transfected cells also indicated that the majority of these mutant receptors were approximately100 kDa in size, which corresponded to the single-chain TSHr with immature, high mannose glycan, whereas the 120-kDa protein, representing the mature TSHr with complex carbohydrate (18, 19) , was barely detectable ( Fig. 5 ). Cells transfected with cysteine mutant ECDholoreceptor constructs did not bind TSH and showed no response to maximal stimulation with TSH (100 mU/ml) (data not shown). However, despite the low level of receptor expression at the cell membrane, cells transfected with cysteine mutants showed increased cAMP production above that of vector, indicating constitutive activity of these receptors (Table 1 ). When normalized to the level of expression (as measured by FACS on nonpermeabilized cells), constitutive activity of the mutants was higher than that of the WT receptor ( Fig. 6 ). However, constitutive activity did not reach the level achieved by an S281N mutant (Fig. 6) .
Considering that mutation of Ser 281 to Asn, Thr, or Ile lead to a strong increase in constitutive activity of the TSHr ( Table 2 and Refs. 11 and 12), we explored whether these amino acid substitutions were merely disrupting a silencing interaction of the ECD with the serpentine (loss of structure), or if a gain of structure was involved. Ser 281 was mutated to Ala and Gly, and the basal activity of the mutant receptors was tested by transfection in COS cells. Alanine substitution is expected to affect minimally the backbone structure, whereas disrupting side-chain-mediated polar or ionic interactions. On the contrary, substitution by glycine may induce significant change in the backbone conformation by introducing a local flexibility (20) . Both mutants were well expressed at the cell surface ( Table 2 ). Whereas the S281G mutant displayed increase in constitutive activity of the same magnitude as the cysteine mutants, basal activity of the S281A was similar or even lower when compared with the WT receptor ( Table 2 and Fig. 6 ).
Discussion
Previous studies on Cys 283 and 284 had involved only single mutation at either member of the pair of consecutive cysteine residues (21) . Also, the effects of the mutations of these residues, as well as of other cysteines, were appreciated mainly on functional parameters (TSH binding or cAMP response to TSH), with little information on the level of expression of the mutant proteins at the cell surface (21) (22) (23) . Consequently, many cysteine residues located in the ECD and the extracellular loops of the serpentine portion of the TSHr were interpreted to be important for maintaining TSH binding or signal transduction based on incomplete evidence. In the present study, we evaluated the effects of single and double mutations at position s283 and 284, both on functional parameters and targeting to the plasma membrane.
As we have shown clearly in our experiments involving ECD-holoreceptor mutant, most of the mutated receptors failed to traffic to cell surface and were sequestrated intracellularly. The mutant receptors trapped internally were predominantly approximately 100 kDa in size, corresponding to forms linked to immature, high mannose glycans (19) . Scarce amount of the mature holoreceptor (ϳ120 kDa) could only be detected on immunoblotting, which agreed with the results of FACS analyses. Therefore, the failure of ligand binding in these instances is likely attributable to lack of receptor expression rather than modification of the ligand binding site. Expression of the same mutants on a GPI-anchor background promoted the efficient targeting of some of them to the cell surface, thus allowing, for the first time, assessment of the relative importance of Cys 283 and 284 in TSH binding. Keeping Cys 283 intact in the ECD (as in S281HCS-GPI) is compatible with specific binding of TSH, with dissociation constant similar to the WT receptor. Mutation of this residue (in S281HSC-GPI) abolished ligand binding and emphasized the critical role of Cys 283 in maintaining the conformation of the TSH binding site.
Precise interpretation of these experiments and of those of previous studies (21-23) would require knowledge of the partnering cysteine residues involved in individual disulfide bonds. The difference in behavior of our mutants, when expressed on a GPI or holoreceptor background, could be secondary to differences in the nature of illegitimate disulfide bonds that may take place in the mutants. Apart from the mutated residues, the GPI-based constructs contain all cysteines present in the WT ECD. In the holoreceptor-based mutants, the additional cysteines present in the first and second extracellular loops (which are thought to make a disulfide bond in most GPCRs) might participate in illegitimate bonds, thus causing misfolding and trapping of the mutant proteins in the endoplasmic reticulum. It would be of interest to extend the present study by testing all combinations of S281HCS, S281HSC, and S281HSS mutations with mutations of Cys494 and Cys569 in the first and second exoloops, respectively.
The TSHr displays significant basal activity, when expressed by transfection in heterologous cells (24, 25) , and this constitutive activity can be increased by a wide spectrum of mutations (1-9). The activating mutations affecting residues FIG. 3. Binding of 125 I-labeled TSH to ECD-GPI mutants. A, 300,000 cells of each construct were incubated with 100,000 cpm/ml 125 Ilabeled TSH in the absence or presence of unlabeled TSH. S281HCS ECD-GPI construct showed significant TSH binding that was displaceable with unlabeled TSH. Columns represent mean; error bars denote SE (n ϭ 6). B, WT S281HCC and mutant S281HCS showed similar displacement of I 125 -labeled TSH binding by unlabeled TSH. The dissociation constants were 2.1 mUI/ml and 1.6 mUI/ml, respectively.
of the serpentine portion of the receptor are in agreement with the current model for GPCR activation, wherein equilibrium would exist between constrained inactive conformation and relaxed active conformation (26) . The existence of activating mutations affecting a residue of the ECD, Ser281, led us to propose that, in the TSHr, the ECD would contribute to stabilization of an inactive conformation of the serpentine by exerting a silencing effect via interaction with the exoloops (11) . This model predicts that disruption of the WT structure of the ECD, or mere removal of the ECD, would lead to receptor activation in the absence of TSH. In this context, mutations causing disruption of disulphide bond(s) in the vicinity of Ser281, via mutations of Cys 283 and/or Cys 284, would be expected to trigger receptor activation. Indeed, all three cysteine mutant ECD-holoreceptors displayed constitutive activity at levels higher than the WT. Also, when expressed alone as a truncated structure devoid of its aminoterminal ECD, the serpentine portion of the TSHr displays increase in constitutive activity, when compared with the WT holoreceptor [ (14) and our unpublished data]. In both cases, however, the basal activity did not reach the level achieved by S281N. An attractive possibility would be that mutations affecting Ser281 would cause a conformational change, acting as a switch, transforming domain of the ECD with a silencing effect on the serpentine into a structure endowed with stimulatory activity. This model would account for the observation that mutations affecting Ser281 of the TSHr [or Ser277 of the LHr (27) ] cause increase in constitutive activity, in relation with the expected effects of the amino acid substitutions on disruption of the local structure. Substitutions by alanine are virtually neutral, with no stimulatory effect on basal activity; whereas substitutions by glycine, threonine, or FIG. 4. Analyses of cells transfected with mutant ECD-holoreceptor constructs by flow cytometry. The thick-line histograms display the results obtained with cells transfected with the pCDNA3 vector alone. The thin-line histograms illustrate the results obtained with cells transfected with the constructs indicated on the top of the figure. A, Studies done on intact cells labeled with BA8 showed limited cell surface expression of all the cysteine mutants; B, the mAb 15.2 could detect higher levels of mutant receptor expression on the same population of cells; C, permeabilization of the cells indicated that BA8 was able to recognize the mutated ECDs, and the majority of these receptors were located in the intracellular compartment. The arbitrary fluorescence unit of vector-transfected cells is indicated below each panel, whereas the fluorescence unit of cells transfected with the constructs is shown at the top right-hand corner of each histogram box. Data shown are representative results of more than three repeated experiments. asparagine (Fig. 6) or, more so, by isoleucine lead to stronger activation (12, 27) . The mutations with more drastic effects on structure would trigger the switch more efficiently. The model leads to the suggestion that activation of the receptors by their natural agonists could involve a similar mechanism, switching a silencing effect of the unliganded ECD into a stimulatory effect induced by hormone binding. Alternative hypotheses have been proposed, involving a direct stimulatory effect of the ␣-subunits of glycoprotein hormones on the serpentine portion of the receptor (28) . Further work will explore the relevance of the above model in the cases of the noisy TSHr and the silent LHr and FSH receptor and will attempt identification of the residues involved both in the putative switch domain of the ECD and its interacting partner in the exoloops of the serpentine domain.
FIG. 5. Western blot of receptor proteins probed with the mAb 28. Lane 1, WT TSHr showing three bands at approximately 120, 100, and 60 kDa, corresponding to the mature holoreceptor, the immature glycosylated protein, and the ␣-subnit, respectively; lanes 2-4, cysteine mutants in the following order: S281HSS, S281HSC, and S281HCS. Small amounts of mature receptors were detected in S281HSS and S281HSC, whereas none was observed with S281HCS. The data are in agreement with level of receptor expression, as assessed by FACS analysis. For the three cysteine mutants, nearly all of the receptors existed as immature glycosylated form, and no ␣subunits were visible on immunoblotting. Expressions of wild-type and mutant receptors in transiently transfected COS cells were detected with the mAb 15.2. All three cysteine mutants showed poor cell surface receptor expression. cAMP assayed under basal condition indicated increased cAMP production above that of vector indicating constitutive activity. The cAMP experiments were performed in triplicate and repeated thrice.
a Mean Ϯ SE (n ϭ 3).
FIG. 6. RSCA of the serine and cysteine mutants, computed with the formula described in Materials and Methods. All three cysteine mutants were constitutively active, though less than the S281N mutant. Mutation of serine 281 to alanine, where disruption of local structure is expected to be minimal, displayed the lowest constitutive activity (see Discussion). Columns represent mean; error bars denote SE. For S281 mutants, the experiment was done in triplicate. For cysteine mutants, experiments were performed thrice in triplicate. Serine at position 281 was mutated to alanine, glycine, threonine, and asparagine; and the expression levels and functional characteristics were assayed by flow cytometry and cAMP determination, after transient transfection in COS cells. The experiment was performed in triplicate.
